Southern Double Long Hynix Rises 1062% This Year
On June 22, the Southern Double Long Hynix continued its strong upward trend. By the close of today, the ETF's secondary market increase was 16.55%, bringing its cumulative increase for the year to 1061.92%. The continuous rise of this ETF is attributed to the strong performance of SK Hynix. During today's trading, SK Hynix briefly rose over 6%, reaching a new high, and its market capitalization temporarily surpassed that of Samsung Electronics, making it the highest-valued company in South Korea.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
European Central Bank board member warns: The Middle East energy shock has not yet affected wages, and the longer the conflict lasts, the greater the risks become.
European Central Bank member Rehn stated that the energy shock in the Middle East has not yet affected prices and wages, but the longer the conflict lasts, the greater the risk of transmission; the central bank has already raised interest rates twice, and rates may be raised again.
Silver price today: Silver broadly unchanged, according to FXStreet data
IREM names Kim Woo-jin, Sung Young-chul, Lee Hyung-do as director nominees in corrected filing
IREM issued a correction to its Sept. 4 board resolution calling an extraordinary shareholders’ meeting, updating the agenda to specify three director appointments. The meeting is scheduled for Oct. 21 at 9 a.m. at the company’s headquarters in Buan, North Jeolla Province. The revised slate includes the reappointment of CEO Woojin Kim as an inside director for a three-year term. The revised slate includes the appointment of Youngcheol Seong as an inside director for a three-year term. The revised slate includes the appointment of Hyungdo Lee as an independent director for a three-year term. The correction dated Oct. 6 was filed to reflect the finalized agenda items. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. IREM Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261006900738), on October 06, 2026, and is solely responsible for the information contained therein.
TRex Bio (TRXB.US) IPO priced at $14-16 per share, plans to raise $125 million; Eli Lilly intends to subscribe for $13 million
TRex Bio announced the terms of its initial public offering (IPO) on Monday.
Crypto prices
More
